BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22214378)

  • 1. Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.
    Lenhard M; Tsvilina A; Schumacher L; Kupka M; Ditsch N; Mayr D; Friese K; Jeschke U
    BMC Cancer; 2012 Jan; 12():2. PubMed ID: 22214378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients.
    Engelstaedter V; Heublein S; Schumacher AL; Lenhard M; Engelstaedter H; Andergassen U; Guenthner-Biller M; Kuhn C; Rack B; Kupka M; Mayr D; Jeschke U
    BMC Cancer; 2012 Dec; 12():600. PubMed ID: 23241107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of hCG and LHCGR expression patterns with clinicopathological parameters in ovarian cancer.
    Zhong Y; Wang Y; Huang J; Xu X; Pan W; Gao S; Zhang Y; Su M
    Pathol Res Pract; 2019 Apr; 215(4):748-754. PubMed ID: 30712886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR) and hCG protein in ovarian cancer tissues].
    Szajnik M; Nowak-Markwitz E; Szczepański MJ; Spaczyński M
    Ginekol Pol; 2007 Dec; 78(12):939-43. PubMed ID: 18411916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
    Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
    BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
    Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
    J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endocrine profiles and gonadotropin response to Gn-RH of men with testicular cancer].
    Watanabe M; Fuji K; Suzuki K; Kitamura T; Okumura D; Kasahara T; Igarashi T; Masuyama T; Hiramori T; Higaki M; Yoshida H
    Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):543-50. PubMed ID: 12910930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer.
    Ind T; Iles R; Shepherd J; Chard T
    Br J Obstet Gynaecol; 1997 Sep; 104(9):1024-9. PubMed ID: 9307529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chorionic gonadotropin, follicle-stimulating hormone, and luteinizing hormone in patients with epithelial ovarian carcinoma.
    Mählck CG; Grankvist K; Kjellgren O; Bäckström T
    Gynecol Oncol; 1990 Feb; 36(2):219-25. PubMed ID: 2105262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal fluid and HCG influence on steroid production from ovarian tumor tissue, in vitro.
    Ridderheim M; Mählck CG; Selstam G; Stendahl U; Bäckström T
    Anticancer Res; 1994; 14(5A):1753-8. PubMed ID: 7531411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.
    Lenhard M; Tereza L; Heublein S; Ditsch N; Himsl I; Mayr D; Friese K; Jeschke U
    BMC Cancer; 2012 Nov; 12():553. PubMed ID: 23176303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of insulin-like growth factor-1 by hCG.
    Kuroda H; Mandai M; Konishi I; Yura Y; Tsuruta Y; Hamid AA; Nanbu K; Matsushita K; Mori T
    Int J Cancer; 1998 May; 76(4):571-8. PubMed ID: 9590136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
    Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
    Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
    Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
    Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
    APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycodelin in ovarian serous carcinoma: association with differentiation and survival.
    Mandelin E; Lassus H; Seppälä M; Leminen A; Gustafsson JA; Cheng G; Bützow R; Koistinen R
    Cancer Res; 2003 Oct; 63(19):6258-64. PubMed ID: 14559812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropins and female sex steroid hormones in cyst fluid and serum from patients with ovarian tumors.
    Thomas CM; Boss EA; Boonstra H; van Tienoven D; Sweep CG; Massuger LF
    Eur J Gynaecol Oncol; 2008; 29(5):468-72. PubMed ID: 19051814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM
    BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in ovarian luteinizing hormone and follicle-stimulating hormone receptor content and in gonadotropin-induced ornithine decarboxylase activity during prepubertal and pubertal development of the female rat.
    White SS; Ojeda SR
    Endocrinology; 1981 Jul; 109(1):152-61. PubMed ID: 6263582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.